MeVis Medical Solutions AG (M3V) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MeVis Medical Solutions AG (M3V) has a cash flow conversion efficiency ratio of 0.005x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€96.63K ≈ $112.97K USD) by net assets (€17.83 Million ≈ $20.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of MeVis Medical Solutions AG to measure how many days the company can operate on defensive assets alone.
MeVis Medical Solutions AG - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how MeVis Medical Solutions AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
MeVis Medical Solutions AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MeVis Medical Solutions AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Estoril Sol SGPS SA
LS:ESON
|
0.084x |
|
Lokotech Group AS
OL:LOKO
|
-0.587x |
|
Razor Labs Ltd
TA:RZR
|
2.512x |
|
Asia Plastic Recycling Holding Ltd
TW:1337
|
-0.017x |
|
Sportshero Ltd
AU:SHO
|
1.185x |
|
Oceanpal Inc
NASDAQ:OP
|
-0.007x |
|
Upsales Technology AB
ST:UPSALE
|
0.461x |
|
Very Good Tour Co. Ltd
KQ:094850
|
-0.017x |
Annual Cash Flow Conversion Efficiency for MeVis Medical Solutions AG (2006–2025)
The table below shows the annual cash flow conversion efficiency of MeVis Medical Solutions AG from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see MeVis Medical Solutions AG market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €17.83 Million ≈ $20.84 Million |
€3.88 Million ≈ $4.54 Million |
0.218x | +23.29% |
| 2024-09-30 | €17.83 Million ≈ $20.84 Million |
€3.15 Million ≈ $3.68 Million |
0.177x | -46.25% |
| 2023-09-30 | €17.83 Million ≈ $20.84 Million |
€5.85 Million ≈ $6.84 Million |
0.328x | +20.52% |
| 2022-09-30 | €17.83 Million ≈ $20.84 Million |
€4.86 Million ≈ $5.68 Million |
0.272x | -46.80% |
| 2021-09-30 | €17.83 Million ≈ $20.84 Million |
€9.13 Million ≈ $10.68 Million |
0.512x | +215.97% |
| 2020-09-30 | €17.83 Million ≈ $20.84 Million |
€2.89 Million ≈ $3.38 Million |
0.162x | -55.84% |
| 2019-09-30 | €17.83 Million ≈ $20.84 Million |
€6.54 Million ≈ $7.65 Million |
0.367x | +113.19% |
| 2018-09-30 | €32.06 Million ≈ $37.48 Million |
€5.52 Million ≈ $6.45 Million |
0.172x | -23.55% |
| 2017-09-30 | €32.51 Million ≈ $38.01 Million |
€7.32 Million ≈ $8.56 Million |
0.225x | +111.15% |
| 2016-09-30 | €32.89 Million ≈ $38.45 Million |
€3.51 Million ≈ $4.10 Million |
0.107x | -45.32% |
| 2015-09-30 | €33.73 Million ≈ $39.43 Million |
€6.58 Million ≈ $7.69 Million |
0.195x | +22.25% |
| 2014-09-30 | €30.27 Million ≈ $35.39 Million |
€4.83 Million ≈ $5.65 Million |
0.160x | -43.60% |
| 2013-09-30 | €26.45 Million ≈ $30.92 Million |
€7.48 Million ≈ $8.75 Million |
0.283x | +21.84% |
| 2012-09-30 | €22.77 Million ≈ $26.62 Million |
€5.29 Million ≈ $6.18 Million |
0.232x | -5.73% |
| 2011-09-30 | €20.73 Million ≈ $24.23 Million |
€5.11 Million ≈ $5.97 Million |
0.246x | +23.38% |
| 2010-09-30 | €24.79 Million ≈ $28.98 Million |
€4.95 Million ≈ $5.79 Million |
0.200x | +112.02% |
| 2009-09-30 | €32.61 Million ≈ $38.12 Million |
€3.07 Million ≈ $3.59 Million |
0.094x | +5.62% |
| 2008-09-30 | €32.61 Million ≈ $38.13 Million |
€2.91 Million ≈ $3.40 Million |
0.089x | +211.17% |
| 2007-09-30 | €30.77 Million ≈ $35.97 Million |
€-2.47 Million ≈ $-2.89 Million |
-0.080x | -104.63% |
| 2006-09-30 | €2.65 Million ≈ $3.10 Million |
€4.59 Million ≈ $5.37 Million |
1.732x | -- |
About MeVis Medical Solutions AG
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also of… Read more